Association between antimicrobial consumption and clinical isolates of methicillin-resistant Staphylococcus aureus: a 14-year study

[1]  C. Seas,et al.  [The changing pattern of methicillin-resistant Staphylococcus aureus clones in Latin America: implications for clinical practice in the region]. , 2010, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

[2]  Henry F. Chambers,et al.  Waves of resistance: Staphylococcus aureus in the antibiotic era , 2009, Nature Reviews Microbiology.

[3]  L. Cui,et al.  Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus by Imipenem , 2009, Antimicrobial Agents and Chemotherapy.

[4]  H. Boucher,et al.  Epidemiology of methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  E. Tacconelli,et al.  Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. , 2007, The Journal of antimicrobial chemotherapy.

[6]  A. Friedrich,et al.  The molecular evolution of methicillin-resistant Staphylococcus aureus. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  J. Boyce,et al.  Emergence and resurgence of meticillin-resistant Staphylococcus aureus as a public-health threat , 2006, The Lancet.

[8]  D. Sahm,et al.  Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States , 2006, Annals of Clinical Microbiology and Antimicrobials.

[9]  S. Cosgrove,et al.  The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges , 2005, Infection Control & Hospital Epidemiology.

[10]  Y. Carmeli,et al.  Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients , 2003, Emerging infectious diseases.

[11]  H. Chambers,et al.  Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods , 2003, Antimicrobial Agents and Chemotherapy.

[12]  S. Cosgrove,et al.  Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  F. Colardyn,et al.  Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. , 2002, Archives of internal medicine.

[14]  R. Venezia,et al.  Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. , 2002, The Journal of antimicrobial chemotherapy.

[15]  J. Turnidge,et al.  High Prevalence of Oxacillin-Resistant Staphylococcus aureus Isolates from Hospitalized Patients in Asia-Pacific and South Africa: Results from SENTRY Antimicrobial Surveillance Program, 1998-1999 , 2002, Antimicrobial Agents and Chemotherapy.

[16]  D. Austin,et al.  Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: fitting a model to the data. , 2002, The Journal of infectious diseases.

[17]  M. Lipsitch,et al.  Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  J. Jorgensen,et al.  Association of Antibiotic Utilization Measures and Control of Multiple-Drug Resistance in Klebsiella pneumoniae , 2000, Infection Control & Hospital Epidemiology.

[19]  Y. Carmeli,et al.  The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. , 1999, Archives of internal medicine.

[20]  N. Crowcroft,et al.  Methicillin-Resistant Staphylococcus Aureus and Antimicrobial Use in Belgian Hospitals , 1999, Infection Control & Hospital Epidemiology.

[21]  D. Horn,et al.  Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella. , 1998, JAMA.

[22]  J. Burke.  Antibiotic resistance--squeezing the balloon? , 1998, JAMA.

[23]  K. Shimada,et al.  Antimicrobial susceptibility of pathogens isolated from more than 10 000 patients with infectious respiratory diseases: a 25-year longitudinal study , 2009, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[24]  A. Friedrich,et al.  Deurenberg, R. H. et al. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin. Microbiol. Infect. 13, 222-235 , 2007 .

[25]  S. Cosgrove,et al.  Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.